Title APSC Consensus for the use of Ticagrelor in Asia, Rethinking DAPT: Implementing the Latest Evidence in Antiplatelet Regimens to Clinical Practice 
Date 30 July 2020, Thursday
Time 1600 - 1730 Singapore Time / 1700 - 1830 Japan Time / 0800 - 0930 GMT




REGISTER NOW

Registration is on first-come-first-served basis.
By registering for the Webinar, you agree to our Privacy Policy

Topics

APSC Consensus statement on Ticagrelor - Prof Gilles Montalescot 

Newer oral antiplatelet strategies with a focus on Ticagrelor monotherapy - Prof Roxana Mehran

APSC Consensus on CCS management - Dr Sidney Lo

Chair

Adj Assoc Prof Jack Tan
Deputy Head & Senior Consultant
National Heart Centre Singapore
President, Asian Pacific Society of Cardiology
Singapore

Speakers

Prof Gilles Montalescot 
Chief, Department of Cardiology
Pitié-Salpêtrière Hospital
France

Prof Roxana Mehran
Professor of Medicine
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai School of Medicine
United States

Dr Sidney Lo
Senior Staff Cardiologist
Director of Cardiac Catheterisation Laboratories
Liverpool Hospital
Australia


Panelists

Dr Cynthia Papendick
Emergency Physician 
Royal Adelaide Hospital
Australia

Prof Upendra Kaul
Chairman & Dean Academics and Research
Batra Hospital and Medical Research Center
India

Prof Junya Ako
Associate Professor, Department of Cardiology
Juntendo University Nerima Hospital
Japan

Assoc Prof I-Chang Hsieh 
Associate Professor
Director, PCI Center
Chang Gung Memorial Hospital
Taiwan

Prof Yi-Heng Li 
Professor, Department of Internal Medicine
National Cheng Kung University Hospital
Taiwan

Dr Byeong-Keuk Kim
Division of Cardiology
Yonsei University College of Medicine, Severance Hospital
South Korea

Supported by


>